Q&A: Vanderbilt's Roden Discusses Use of EMRs to Find Gene Variants Linked to Drug Response

Vanderbilt University's Dan Roden is leading a project to identify clinically validated gene variants linked to drug response and generate a list of such important variants that will aid healthcare providers recognize pharmacogenomics opportunities in the care of their patients.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.